Sign in
PHASE I CLINICAL TRIAL OF CD19-TARGETED 19-28Z/4-1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION
Journal article   Peer reviewed

PHASE I CLINICAL TRIAL OF CD19-TARGETED 19-28Z/4-1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION

C.L. Batlevi, M.L. Palomba, J. Park, E. Mead, B. Santomasso, I. Riviere, X. Wang, B. Senechal, R. Furman, J. Yang, …
Hematological oncology, Vol.37(S2), pp.166-167
2019-06

Metrics

8 Record Views

Details